Patent · US Active

Protease stabilized, acylated insulin analogues

US9045560B2 · kind B2 · utility

11Cited by
3References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 2013
Grant dateJun 2, 2015
Priority date—
Expiry dateAug 22, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel acylated insulin analogues exhibiting resistance towards proteases can, effectively, be administered pulmonary or orally. The insulin analogues contain B25H and A14E or A14H.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.